Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cantabell vs Candemore Plus in Hypertension
NCT04521023Phase 4Completed
- Sponsor
- Chong Kun Dang Holdings
- Start
- Sep 2017
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Cantabell in hypertension (HTN), sponsored by Chong Kun Dang Holdings. Started Sep 2017; status: completed.
02
Drugs
Cantabell
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT04521023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04521023.